Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Antibody symbols : AZNCF save search
Antibody Therapeutics Market Size to Grow USD 364180 Million by 2029 at a CAGR of 11% | Valuates Reports
Published: 2024-01-21 (Crawled : 16:20) - prnewswire.com
JNJ | News | $148.53 -0.69% 0.18% 7.5M
|
Health Technology
| Email alert
Add to watchlist
AZNCF | News | $135.35 -3.53% -4.19% 400
|
Health Technology
| Email alert
Add to watchlist
AZN | News | $71.2 0.49% 0.46% 5.4M
|
Health Technology
| Email alert
Add to watchlist
antibody million therapeutics market
Global Respiratory Syncytial Virus (RSV) Vaccine and Antibody Pipeline Market Forecasts to 2030
Published: 2023-09-15 (Crawled : 17:00) - prnewswire.com
SNYNF | News | $94.0 -0.27% -2.18% 310
|
Health Technology
|
| O: 1.53%
H: 0.0%
C: 0.0%
AZNCF | News | $135.35 -3.53% -4.19% 400
|
Health Technology
|
| O: 3.97%
H: 0.0%
C: 0.0%
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: 0.0%
AZN | News | $71.2 0.49% 0.46% 5.4M
|
Health Technology
|
| O: 1.27%
H: 0.38%
C: -0.54%
antibody vaccine respiratory pipeline global virus market
Anti-CD20 Monoclonal Antibodies (mABs) Market size to increase by USD 9.05 Bn | 9.0% YOY growth expected in 2022 | Technavio
Published: 2022-05-25 (Crawled : 04:00) - prnewswire.com
AZNCF | News | $135.35 -3.53% -4.19% 400
|
Health Technology
|
| O: -1.42%
H: 2.73%
C: 2.73%
NVSEF | News | $96.0 0.94% 6.88% 0
|
Health Technology
|
| O: 0.89%
H: 0.0%
C: 0.0%
NVS | News | $98.35 1.1% 0.69% 2.1M
|
Health Technology
|
| O: 0.29%
H: 0.0%
C: 0.0%
AZN | News | $71.2 0.49% 0.46% 5.4M
|
Health Technology
|
| O: -0.45%
H: 0.89%
C: 0.54%
AMGN | News | $273.01 -0.19% -0.17% 1.5M
|
Health Technology
|
| O: 1.42%
H: 0.72%
C: 0.0%
cd20 expected growth market antibody
LifeArc co-founded company RQ Bio signs licensing agreement with AstraZeneca worth up to $157m plus royalties for monoclonal antibodies against SARS-CoV-2
Published: 2022-05-17 (Crawled : 07:00) - prnewswire.com
AZNCF | News | $135.35 -3.53% -4.19% 400
|
Health Technology
|
| O: 4.22%
H: 0.0%
C: -2.05%
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: 1.5%
H: 0.64%
C: 0.19%
AZN | News | $71.2 0.49% 0.46% 5.4M
|
Health Technology
|
| O: 3.17%
H: 0.0%
C: 0.0%
royalties sars-cov-2 license antibody
Global RSV Vaccine and Antibody Pipeline Market: Compound Annual Growth of 38.9% Forecast During 2024-2028
Published: 2022-05-16 (Crawled : 19:00) - prnewswire.com
AZNCF | News | $135.35 -3.53% -4.19% 400
|
Health Technology
|
| O: 4.22%
H: 0.0%
C: -2.05%
JNJ | News | $148.53 -0.69% 0.18% 7.5M
|
Health Technology
|
| O: 1.08%
H: 0.0%
C: 0.0%
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: 1.5%
H: 0.64%
C: 0.19%
AZN | News | $71.2 0.49% 0.46% 5.4M
|
Health Technology
|
| O: 3.17%
H: 0.0%
C: 0.0%
antibody vaccine growth
Global Cancer Antibody Drug Conjugates Industry, 2022-2028 - A $25B+ Opportunity Assessment with Daiichi Sankyo, Roche, Gilead Sciences, ADC Therapeutics, AstraZenca, and Seagen Dominating
Published: 2022-03-01 (Crawled : 20:00) - prnewswire.com
AZNCF | News | $135.35 -3.53% -4.19% 400
|
Health Technology
|
| O: 0.37%
H: 2.02%
C: 2.02%
AZN | News | $71.2 0.49% 0.46% 5.4M
|
Health Technology
|
| O: -0.62%
H: 0.0%
C: 0.0%
drug therapeutics cancer antibody
Gainers vs Losers
| 61% | 39% |
Top 10 Gainers
CSSE 4 | $0.4253 179.25% 64.77% 210M
|
Consumer Services
BOF | $2.08 77.78% 41.21% 110M
|
ILAG | $0.54 12.27% 40.62% 3.7M
|
LICN | $0.999 78.39% 40.49% 15M
|
AMST | $3.4 70.0% 39.58% 70M
|
Technology Services
MTC | $3.6 60.71% 38.04% 9.1M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.458 14.5% 30.92% 91K
|
Health Services
WHLM | $6.25 35.87% 28.46% 700K
|
Commercial Services
MULN | News | $3.77 38.1% 27.78% 13M
|
Information
Your saved searches
Save your searches and get alerts when important news are released.